Matches in Ubergraph for { <https://frink.apps.renci.org/.well-known/genid/B00ad9ec07bb137f1a5ed895dc8826052> ?p ?o ?g. }
Showing items 1 to 5 of
5
with 100 items per page.
- B00ad9ec07bb137f1a5ed895dc8826052 NCIT_P378 "NCI" @default.
- B00ad9ec07bb137f1a5ed895dc8826052 type Axiom @default.
- B00ad9ec07bb137f1a5ed895dc8826052 annotatedProperty IAO_0000115 @default.
- B00ad9ec07bb137f1a5ed895dc8826052 annotatedSource NCIT_C151927 @default.
- B00ad9ec07bb137f1a5ed895dc8826052 annotatedTarget "A long-acting immunoglobulin (Ig) fusion protein composed of a recombinant form of the endogenous human protein interleukin-7 (rhIL-7) and fused to a hybrid Fc (hyFc) region of a human antibody, with hematopoietic and immunopotentiating activities. Upon administration of efineptakin alfa, IL-7 stimulates the proliferation, differentiation, trafficking and survival of a variety of T-cell subsets, including naive, central memory (CM), effector memory (EM), terminally differentiated effector memory (TEMRA) and natural killer (NK) T-cells, and enhances T-cell-mediated anti-tumor immune responses. Compared to rhIL-7 alone, fusion to the hyFc region enhances the half-life of IL-7. The hyFc region is composed of the hinge and N-terminal portion of heavy chain constant (CH) region 2 (hinge-CH2) of human IgD, which is fused to the C-terminal region of CH2 and the entire CH3 region of human IgG4." @default.